MOH — authorised 30 May 2007
- Marketing authorisation holder: PF PRISM CV
- Status: likely_approved
MOH authorised Torisel on 30 May 2007
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 30 May 2007.
PF PRISM CV holds the Israeli marketing authorisation.